Publications for all Oxford Principal Investigators within the CAMS Oxford Institute are included here, please use the search functions for publications related to specific Principal Investigators.
Oligomerization-driven avidity correlates with SARS-CoV-2 cellular binding and inhibition.
Journal article
Asor R. et al, (2024), Proceedings of the National Academy of Sciences of the United States of America, 121
Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
Journal article
Suwarti S. et al, (2024), BMC infectious diseases, 24
Concerted deletions eliminate a neutralizing supersite in SARS-CoV-2 BA.2.87.1 spike.
Journal article
Duyvesteyn HME. et al, (2024), Structure (London, England : 1993)
The effect of pH on the structure of Bluetongue virus VP5.
Journal article
Zhang H. et al, (2024), The Journal of general virology, 105
Immunogenicity of Abdala COVID-19 vaccine in Vietnamese people after primary and booster vaccinations: a prospective observational study in Vietnam.
Journal article
Thanh TT. et al, (2024), International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
The impact of exchanging the light and heavy chains on the structures of bovine ultralong antibodies
Journal article
Clarke JD. et al, (2024), Acta Crystallographica Section F Structural Biology Communications, 80, 154 - 163
Improving the representativeness of UK’s national COVID-19 Infection Survey through spatio-temporal regression and post-stratification
Journal article
Pouwels KB. et al, (2024), Nature Communications, 15
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity
Journal article
Liu C. et al, (2024), Cell Reports Medicine, 5, 101553 - 101553
Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium
Journal article
Nhu LNT. et al, (2024), Wellcome Open Research, 9, 181 - 181
Author Correction: Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses.
Journal article
Michael BD. et al, (2024), Nature communications, 15
Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection.
Journal article
Liu C. et al, (2024), Nature communications, 15
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86.
Journal article
Zhou D. et al, (2024), Nature communications, 15
Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population
Journal article
Wei J. et al, (2024), Nature Communications, 15
Emerging Enterovirus A71 Subgenogroup B5 Causing Severe Hand, Foot, and Mouth Disease, Vietnam, 2023
Journal article
Chau NVV. et al, (2024), Emerging Infectious Diseases, 30
Delayed mucosal anti-viral responses despite robust peripheral inflammation in fatal COVID-19.
Journal article
Sidhu JK. et al, (2023), The Journal of infectious diseases
Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses.
Journal article
Michael BD. et al, (2023), Nature communications, 14
Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera
Journal article
Roper KJ. et al, (2023), Scientific Reports, 13
Structural comparison of typical and atypical E2 pestivirus glycoproteins.
Journal article
Aitkenhead H. et al, (2023), Structure (London, England : 1993)
COVID-19 therapeutics: stewardship in England and considerations for antimicrobial resistance.
Journal article
Bou-Antoun S. et al, (2023), The Journal of antimicrobial chemotherapy, 78, ii37 - ii42
Persistence of SARS-CoV-2 antibodies over 18 months following infection: UK Biobank COVID-19 Serology Study.
Journal article
Bešević J. et al, (2023), Journal of epidemiology and community health